glp 1 agonist prescription GLP-1 receptor agonists are promising but unproven treatments for alcohol and substance use disorders Glucagon-like peptide 1 receptor agonist

In CVOTs, liraglutide, semaglutide and dulaglutide demonstrated appreciable cardiovascular and renal protective effects, among which liraglutide had an appreciable effect on mitigating the risk of cardiovascular death [4], while semaglutide and dulaglutide conferred a risk reduction on non-fatal stroke [22, 23]

doi: 10.1053/j.gastro.2015.04.014 quiz e15-6

GLP-1 receptor agonists are MHRA-licensed prescription medicines with extensive clinical trial evidence for type 2 diabetes and obesity management

Everything here reflects what the company has made publicly available on its official website and in its terms of use

2024;166(1):bqae155

If we are simply shrinking patients without preserving their strength, we may be trading one set of problems for another